402 related articles for article (PubMed ID: 8290595)
1. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.
Ray A; Prefontaine KE
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):752-6. PubMed ID: 8290595
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
3. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
Matsusaka T; Fujikawa K; Nishio Y; Mukaida N; Matsushima K; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10193-7. PubMed ID: 8234276
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
6. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors.
Eberhardt W; Schulze M; Engels C; Klasmeier E; Pfeilschifter J
Mol Endocrinol; 2002 Aug; 16(8):1752-66. PubMed ID: 12145332
[TBL] [Abstract][Full Text] [Related]
8. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
Merola M; Blanchard B; Tovey MG
J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines.
Shimizu H; Yamamoto K
Gene; 1994 Nov; 149(2):305-10. PubMed ID: 7959007
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
Stein B; Baldwin AS
Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
[TBL] [Abstract][Full Text] [Related]
11. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation.
Dokter WH; Koopmans SB; Vellenga E
Leukemia; 1996 Aug; 10(8):1308-16. PubMed ID: 8709636
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
De Bosscher K; Vanden Berghe W; Haegeman G
Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation.
De Bosscher K; Schmitz ML; Vanden Berghe W; Plaisance S; Fiers W; Haegeman G
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13504-9. PubMed ID: 9391055
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression.
Mukaida N; Morita M; Ishikawa Y; Rice N; Okamoto S; Kasahara T; Matsushima K
J Biol Chem; 1994 May; 269(18):13289-95. PubMed ID: 8175759
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element.
Alcorn JL; Islam KN; Young PP; Mendelson CR
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L767-76. PubMed ID: 14633512
[TBL] [Abstract][Full Text] [Related]
17. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids.
Ray KP; Farrow S; Daly M; Talabot F; Searle N
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):707-15. PubMed ID: 9371735
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of interleukin-8 gene expression.
Mukaida N; Okamoto S; Ishikawa Y; Matsushima K
J Leukoc Biol; 1994 Nov; 56(5):554-8. PubMed ID: 7525815
[TBL] [Abstract][Full Text] [Related]
19. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
Kunsch C; Lang RK; Rosen CA; Shannon MF
J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]